LES INHIBITEURS DES TYROSINES KINASES

dc.contributor.advisorA. IBRAHIMI
dc.contributor.authorKenza OUARDA
dc.date.accessioned2025-02-21T12:22:41Z
dc.date.accessioned2025-12-17T09:57:42Z
dc.date.available2025-02-21T12:22:41Z
dc.date.issued2017
dc.description.collaboratorJ. EL HARTI
dc.description.collaboratorS. BENKIRANE
dc.description.collaboratorR. NEJJARI
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/36396
dc.identifier.urihttps://doi.org/10.83129/toubkal-8026
dc.language.isofr
dc.publisherFaculté de Médecine et de Pharmacie, Rabat - Thèse de médecinefr_FR
dc.subjectInhibiteurs des tyrosines kinasesfr_FR
dc.subjectThérapie cibléefr_FR
dc.subjectCancerfr_FR
dc.subjectVoies de signalisationfr_FR
dc.subject.ddc616.99
dc.subject.otherBiotechnologie
dc.subject.specificThérapie ciblée en cancérologie
dc.titleLES INHIBITEURS DES TYROSINES KINASESfr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
P 134 2017.pdf
Size:
8.27 MB
Format:
Adobe Portable Document Format